ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

LIAN LianBio

0.319
0.00 (0.00%)
09 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
LianBio LIAN 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.319 09:00:00
개장가 저가 고가 종가 전일 종가
0.319 0.319
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/03/202420:51EDGAR2Form 25 - Notification of the removal from listing and..
28/02/202421:00GLOBELianBio Announces Voluntarily Delisting from Nasdaq
21/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202421:04EDGAR2Form 8-K - Current report
13/02/202421:00GLOBELianBio Announces Completion of Strategic Review
08/01/202420:13EDGAR2Form 144 - Report of proposed sale of securities
29/12/202321:56EDGAR2Form 144 - Report of proposed sale of securities
27/12/202306:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/12/202306:07EDGAR2Form 8-K - Current report
27/12/202304:40APSBiotech Finds Success Following Holiday Weekend
26/12/202316:00GLOBELianBio Enters into Agreement Assigning its Rights for..
20/12/202322:05EDGAR2Form 8-K - Current report
20/12/202322:00GLOBELianBio Announces Departure of Chief Financial Officer
20/12/202306:26EDGAR2Form 8-K - Current report
20/12/202306:05GLOBELianBio Announces Departure of Chief Executive Officer
07/12/202306:23EDGAR2Form 8-K - Current report
07/12/202306:05GLOBELianBio’s Board of Directors Unanimously Determines not to..
02/12/202306:16EDGAR2Form 8-K - Current report
02/12/202306:05GLOBELianBio Confirms Receipt of Unsolicited Proposal from..
14/11/202306:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:17EDGAR2Form 8-K - Current report
14/11/202306:05GLOBELianBio Reports Third Quarter 2023 Financial Results and..
31/10/202305:16EDGAR2Form 8-K - Current report
31/10/202305:05GLOBELianBio Announces Topline Results from Phase 3 LIBRA Trial..
26/10/202305:05GLOBELianBio Announces Presentation of Data from Phase 2a Study..
24/10/202323:25APSBiotech Shares Soar Premarket
24/10/202322:22DJNLianBio Shares Soar Premarket on Strategic Review, End of..
24/10/202319:59GLOBELianBio Enters into Agreement with Bristol Myers Squibb for..
29/08/202305:05GLOBELianBio Announces Results from Phase 3 EXPLORER-CN Trial of..
15/08/202305:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:11EDGAR2Form 8-K - Current report
15/08/202305:05GLOBELianBio Reports Second Quarter 2023 Financial Results and..
04/08/202305:05GLOBELianBio Announces First Patient Treated in Phase 1 Trial of..
26/07/202321:30GLOBELianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA..
18/07/202321:00GLOBELianBio Partner NANOBIOTIX Enters into License Agreement..
17/07/202319:00GLOBELianBio Announces Phase 3 EXPLORER-CN Data Accepted for..
12/07/202321:00GLOBELianBio Announces Clinical Supply Agreement with AstraZeneca..
26/06/202321:00GLOBELianBio Announces Marketing Approval of CAMZYOS®..
08/06/202320:00GLOBELianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial..
08/06/202307:21DJNADRs End Mostly Lower, Oatly and LianBio Trade Actively
07/06/202305:05GLOBELianBio Announces Topline Results from Phase 2a Proof of..
02/06/202305:15GLOBELianBio to Participate in Upcoming Investor Conferences
12/05/202305:15GLOBELianBio Reports First Quarter 2023 Financial Results and..
11/05/202320:00GLOBELianBio Announces Marketing Approval of CAMZYOS®..

최근 히스토리

Delayed Upgrade Clock